Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Androgenetic alopecia in women needs more research and better management strategies.

Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.

Androgenetic alopecia causes gradual hair thinning due to genetics and hormones, with treatment options including scalp prostheses.

The method can help diagnose and monitor diabetes by analyzing hair.

Early balding may be a sign of future prostate problems.

Non-obese women with hair loss have higher heart disease risk.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Androgenetic alopecia worsens with age in Japanese men.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Finasteride effectively treats hair loss, which is influenced by genetics and stress.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Young adults with hair loss face higher risk of stiff arteries.

Plant-based remedies and a multimodal approach can help manage hair loss.

A woman lost all her hair in one day, was diagnosed with a rare type of hair loss, and regrew it in 12 weeks with treatment.

The patient's hair had unique damage and a lower sulfur-to-nitrogen ratio compared to relatives, but not compared to healthy controls.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Channels stay open for 24 hours, making laser treatment potentially effective for hair loss.